Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flo…
Medical - Instruments & Supplies
DE, Göttingen [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 37.57 | 2.02 | 1.47 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -46.07 | 17.11 | 31.72 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 29.23 | 39.05 | 30.22 | |
| Cash | 190.89 | 16.76 | 5.76 | |
| Capex | -2.07 | -1.88 | -1.84 | |
| Free Cash Flow | -50.30 | -1.35 | 2.71 | |
| Revenue | -3.55 | 11.98 | 12.42 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 24.07 | 0.48 | 0.39 | |
| Operating Margin | 123.20 | 0.18 | 0.08 | |
| ROA | -51.11 | < 0.005 | < 0.005 | |
| ROE | -58.78 | 0.01 | 0.03 | |
| ROIC | 199.17 | 0.01 | < 0.005 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of SARTF is permitted for members.
5
Growth
The "Growth Entry" for the Focus of SARTF is permitted for members.
6
Leverage & Liquidity